entertainment -WSS

entertainment

author：knowledge 2025-09-29 22:53:59 - browse：38

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Late stage cancers on the rise after pandemic delayed screenings

hotspot

WSS

FDA scientists endorse Pfizer/BioNTech Covid

BMI, flaws aside, is found to be useful estimate of body fat in youth

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

The Pandemic Treaty must support building strong health systems

Change Healthcare can notify patients about the breach, HHS says

With trial win, GSK could get blood cancer drug back on market

focus

entertainment

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Personalized medicine goes far beyond genetics

BioMarin wins approval for gene therapy to treat hemophilia A

Chris Christie meets with Zelenskyy during Ukraine trip

At least 13 dead in Texas as scorching temps continue

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Wildfire smoke exposes gaps in outdoor worker protections

Flint parents haunted by uncertainty, fears of lead poisoning

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

focus

Physicians aren't 'burning out.' They're suffering from moral injury

With trial win, GSK could get blood cancer drug back on market

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

HIV drugs protect against transmission, even in unprotected sex

A controversial new treatment promises to make little people taller

See how much Covid

knowledge

hotspot

entertainment

hotspot